Puma Biotechnology Inc (PBYI)
4.72
-0.22
(-4.45%)
USD |
NASDAQ |
May 15, 15:36
Puma Biotechnology Cash from Financing (Quarterly): 0.00 for March 31, 2024
Cash from Financing (Quarterly) Chart
Historical Cash from Financing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | 0.00 |
| December 31, 2023 | 0.00 |
| September 30, 2023 | 0.00 |
| June 30, 2023 | 0.00 |
| March 31, 2023 | 0.00 |
| December 31, 2022 | 2.431M |
| September 30, 2022 | -0.053M |
| June 30, 2022 | 0.00 |
| March 31, 2022 | 9.845M |
| December 31, 2021 | -0.002M |
| September 30, 2021 | -31.93M |
| June 30, 2021 | 0.00 |
| March 31, 2021 | 0.00 |
| December 31, 2020 | -9.977M |
| September 30, 2020 | 0.043M |
| June 30, 2020 | 0.002M |
| March 31, 2020 | |
| December 31, 2019 | -0.001M |
| September 30, 2019 | 0.076M |
| June 30, 2019 | -68.22M |
| March 31, 2019 | 1.082M |
| December 31, 2018 | 30.49M |
| September 30, 2018 | 1.01M |
| June 30, 2018 | 73.80M |
| March 31, 2018 | 3.147M |
| Date | Value |
|---|---|
| December 31, 2017 | 61.11M |
| September 30, 2017 | 9.731M |
| June 30, 2017 | 3.565M |
| March 31, 2017 | 0.706M |
| December 31, 2016 | 162.08M |
| September 30, 2016 | 0.129M |
| June 30, 2016 | 0.00 |
| March 31, 2016 | 0.222M |
| December 31, 2015 | 1.32M |
| September 30, 2015 | 5.374M |
| June 30, 2015 | 7.034M |
| March 31, 2015 | 219.63M |
| December 31, 2014 | 6.533M |
| September 30, 2014 | 0.00 |
| June 30, 2014 | 0.00 |
| March 31, 2014 | 129.44M |
| December 31, 2013 | 2.069M |
| September 30, 2013 | 0.146M |
| June 30, 2013 | 0.00 |
| March 31, 2013 | 0.00 |
| December 31, 2012 | 129.26M |
| September 30, 2012 | 0.00 |
| June 30, 2012 | 0.00 |
| March 31, 2012 | 0.00 |
| December 31, 2011 | 56.74M |
Cash From Financing Definition
Cash flow from financing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall financing activities of the company. A few examples of financing activities include common stock issuance, total dividends paid, and net debt issuance.
Cash from Financing (Quarterly) Range, Past 5 Years
-68.22M
Minimum
Jun 2019
9.845M
Maximum
Mar 2022
-5.147M
Average
--
Median
Mar 2021
Cash from Financing (Quarterly) Benchmarks
| ADMA Biologics Inc | -1.447M |
| Pfizer Inc | -4.931B |
| Sarepta Therapeutics Inc | 22.14M |
| Immunogen Inc (DELISTED) | 32.13M |
| United Therapeutics Corp | -1.068B |
Cash from Financing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | 11.25M |
| Cash from Investing (Quarterly) | -19.08M |
| Free Cash Flow | 35.61M |
| Free Cash Flow Per Share (Quarterly) | 0.2334 |
| Free Cash Flow to Equity (Quarterly) | 10.88M |
| Free Cash Flow to Firm (Quarterly) | 13.75M |
| Free Cash Flow Yield | 15.78% |